Dear I have submitted the Outcome of Board meeting held on 27-11-2025 without sign hence submitting it again with signature. Kindly consider the same. Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd held a board meeting on 27 November 2025 with two key outcomes. First, the Board authorized Whole-time Director & CEO Narayan Kutty Menon to identify buyers and negotiate terms for the sale of the Company's factory premises, following shareholder approval obtained via postal ballot on 17 November 2025 under Section 180(1)(a) of the Companies Act. Second, the Board approved the appointment of Ms. Falguni Kumawat (ICSI Membership No. A37989) as the new Company Secretary and Compliance Officer, effective 1 December 2025. She brings 10 years of experience in secretarial, legal, and finance work. The meeting ran from 3:30 p.m. to 5:30 p.m.
The factory premises sale is a significant asset divestment that could unlock cash for the company, while shareholders await the final sale price and use of proceeds. The appointment of a new Company Secretary is a routine compliance change with no direct impact on stock price.